Jubilant Cadista Pharmaceuticals, Inc. 2022-04-06 Health critical FDA
Health · FDA · Recall #FDA-D-0767-2022
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count… Recall
Issued April 6, 2022 · Jubilant Cadista Pharmaceuticals, Inc.
In April 2022, Jubilant Cadista Pharmaceuticals, Inc. recalled the Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
What you should do
- 1 Stop using Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Jubilant Cadista Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Jubilant Cadista Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- April 6, 2022
- Units affected
- Not reported
- Sold at
- Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
- Recall number
- FDA-D-0767-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Jubilant Cadista Pharmaceuticals, Inc. has 2 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.